leisure time -WSS

leisure time

author：hotspot 2025-09-28 23:49:55 - browse：4457

Portrait of Don Davis -- health policy coverage from STAT — U.S. Representative Don Davis (D-N.C.) Wikimedia Commons

WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s Medicare drug price negotiation program managed to find themselves a Democratic co-sponsor — even though every single Democrat in Congress in 2022 voted for the legislation.

They found their perfect candidate in Rep. Don Davis, a Democrat representing a North Carolina district that includes parts of the state’s Research Triangle. He came to Washington in 2023, so didn’t vote on the original law. He received donations in 2023 from the political action committees for Gilead, Astellas, Genentech, Bayer, Pfizer, Novo Nordisk, GSK, Bristol Myers Squibb, BIO, Amgen, Boehringer Ingelheim, Merck, AbbVie, and Eli Lilly.

“We must support the development of critical, life-sustaining medical treatments and cures,” Davis said in a written statement, and a spokesperson declined to elaborate. He is joined on the bill by Rep. Greg Murphy (R-N.C.) and Brett Guthrie (R-Ky.), the Energy and Commerce health subcommittee chairman.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

hotspot

WSS

Prescription digital therapeutics are key to pharma’s future

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Being 'nonadherent' patient made me a more empathetic doctor

Francis Collins on trust in science and how Covid communications failed

A letter from the executive editor: The 2023 STATUS List

Canadians with cystic fibrosis outlive Americans by a decade

focus

leisure time

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Fatty liver disease was alleviated by Lilly’s ‘triple

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

In Memoriam: Notable people who died in 2023

AstraZeneca lung cancer study comes in below expectations

BioMarin wins approval for gene therapy to treat hemophilia A

Hubble vs. James Webb telescope images: See the difference

hotspot

Eli Lilly, Pfizer, and others want in on the online prescription market

The wait for US passports is creating travel purgatory and snarling summer plans

AI generated plenty of interest at JPM but not a lot of trust

Undocumented workers face uncertainty as immigration law takes effect in Florida

UpToDate has a racism problem: Dr. Stanley Goldfarb

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

focus

hotspot

focus

focus